← Back to the boardHill
FDA is taking public comments through January 2027 on a docket tied to a workshop about weighing benefits and risks of robotic medical devices that operate autonomously or via remote teleoperation.
Why it’s here: An FDA public workshop docket on benefit-risk evaluation of autonomous and teleoperated robotic medical devices is a federal regulatory matter touching robotics and autonomy policy, though it centers on medical devices rather than defense or AI policy.
Trace across the boardItem
11:59 PMAgencyFDAFDA is taking public comments through January 2027 on a docket tied to a workshop about weighing benefits and risks of robotic medical devices that operate autonomously or via remote teleoperation.Comment deadlineRoboticsDetails5 linked
Coverage
1 outlets · first seen 9d agoConnected
5 links- NewsFDA warns against online weight-loss drugs containing uncertain ingredientsBoth involve Food and Drug Administration
- NewsUS FDA orders new eye risk warnings for Ozempic, ZepboundBoth involve Food and Drug Administration
- NewsSTAT+: FDA warns GLP-1 drugs carry potential risk of rare eye conditionBoth involve Food and Drug Administration
- HillComments due: Robotically-Assisted Surgical Devices - Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Draft GuidanceBoth involve Food and Drug Administration
- HillComments due: Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities: Discussion Paper and Request for FeedbackBoth involve Food and Drug Administration
About
- Food and Drug Administration